Moore Capital Management LP Purchases 12,004 Shares of Cigna Group $CI

Moore Capital Management LP lifted its position in Cigna Group (NYSE:CIFree Report) by 33.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 48,079 shares of the health services provider’s stock after purchasing an additional 12,004 shares during the quarter. Moore Capital Management LP’s holdings in Cigna Group were worth $13,859,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Dodge & Cox boosted its stake in Cigna Group by 4.0% in the third quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock worth $2,682,231,000 after buying an additional 354,615 shares in the last quarter. Sanders Capital LLC raised its stake in shares of Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after acquiring an additional 35,150 shares in the last quarter. Norges Bank purchased a new position in shares of Cigna Group during the second quarter worth approximately $1,110,426,000. Capital Research Global Investors lifted its holdings in shares of Cigna Group by 140.2% in the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after acquiring an additional 1,855,897 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in shares of Cigna Group by 7.4% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,695,620 shares of the health services provider’s stock worth $777,012,000 after acquiring an additional 186,880 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CI has been the topic of several recent research reports. TD Cowen increased their target price on shares of Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a report on Monday, February 9th. Sanford C. Bernstein raised shares of Cigna Group from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $307.00 to $358.00 in a research note on Thursday, March 12th. Royal Bank Of Canada cut their price objective on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a report on Friday, February 6th. Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Finally, Robert W. Baird lowered their target price on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a report on Thursday, December 11th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $333.11.

Check Out Our Latest Research Report on Cigna Group

Cigna Group Stock Performance

CI stock opened at $268.39 on Tuesday. The stock’s 50 day simple moving average is $279.29 and its 200 day simple moving average is $282.48. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The stock has a market capitalization of $70.73 billion, a PE ratio of 12.10, a price-to-earnings-growth ratio of 0.93 and a beta of 0.27.

Cigna Group (NYSE:CIGet Free Report) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the company earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, research analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be given a $1.56 dividend. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s payout ratio is presently 28.13%.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The SEC filing for this sale provides additional information. 0.70% of the stock is currently owned by insiders.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.